Lymphomatoid granulomatosis risk factors: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 14: Line 14:
**HIV infection<ref name="CostiniukKaramchandani2018">{{cite journal|last1=Costiniuk|first1=Cecilia T.|last2=Karamchandani|first2=Jason|last3=Bessissow|first3=Ali|last4=Routy|first4=Jean-Pierre|last5=Szabo|first5=Jason|last6=Frenette|first6=Charles|title=Angiocentric lymph proliferative disorder (lymphomatoid granulomatosis) in a person with newly-diagnosed HIV infection: a case report|journal=BMC Infectious Diseases|volume=18|issue=1|year=2018|issn=1471-2334|doi=10.1186/s12879-018-3128-3}}</ref>
**HIV infection<ref name="CostiniukKaramchandani2018">{{cite journal|last1=Costiniuk|first1=Cecilia T.|last2=Karamchandani|first2=Jason|last3=Bessissow|first3=Ali|last4=Routy|first4=Jean-Pierre|last5=Szabo|first5=Jason|last6=Frenette|first6=Charles|title=Angiocentric lymph proliferative disorder (lymphomatoid granulomatosis) in a person with newly-diagnosed HIV infection: a case report|journal=BMC Infectious Diseases|volume=18|issue=1|year=2018|issn=1471-2334|doi=10.1186/s12879-018-3128-3}}</ref>
**Drug induced immunodeficiency<ref name="BarakatGrover2014">{{cite journal|last1=Barakat|first1=Athar|last2=Grover|first2=Karan|last3=Peshin|first3=Rohit|title=Rituximab for pulmonary lymphomatoid granulomatosis which developed as a complication of methotrexate and azathioprine therapy for rheumatoid arthritis|journal=SpringerPlus|volume=3|issue=1|year=2014|pages=751|issn=2193-1801|doi=10.1186/2193-1801-3-751}}</ref>
**Drug induced immunodeficiency<ref name="BarakatGrover2014">{{cite journal|last1=Barakat|first1=Athar|last2=Grover|first2=Karan|last3=Peshin|first3=Rohit|title=Rituximab for pulmonary lymphomatoid granulomatosis which developed as a complication of methotrexate and azathioprine therapy for rheumatoid arthritis|journal=SpringerPlus|volume=3|issue=1|year=2014|pages=751|issn=2193-1801|doi=10.1186/2193-1801-3-751}}</ref>
**Organ transplantation
**Organ transplantation<ref name="ShahSmith2018">{{cite journal|last1=Shah|first1=Sujal|last2=Smith|first2=Megan|last3=Butler|first3=Randall|title=A Case of Hodgkin Lymphoma Mimicking Lymphomatoid Granulomatosis Diagnosed at Autopsy|journal=Laboratory Medicine|volume=49|issue=1|year=2018|pages=80–86|issn=0007-5027|doi=10.1093/labmed/lmx065}}</ref>
 





Revision as of 20:25, 7 December 2018

Lymphomatoid granulomatosis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Lymphomatoid granulomatosis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Lymphomatoid granulomatosis risk factors On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Lymphomatoid granulomatosis risk factors

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Lymphomatoid granulomatosis risk factors

CDC on Lymphomatoid granulomatosis risk factors

Lymphomatoid granulomatosis risk factors in the news

Blogs on Lymphomatoid granulomatosis risk factors

Directions to Hospitals Treating Lymphomatoid granulomatosis

Risk calculators and risk factors for Lymphomatoid granulomatosis risk factors

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:

Overview

The risk factor this disease is commonly EBV infection . One my also develop it in a immunodeficient state, organ transplantation , and HIV infection.

Risk Factors

The most potent risk factor in the development of Lymphomatoid granulomatosis is EBV infection. Other risk factors include Drug induced immunodeficiency, Immunodeficient diseases, and HIV infection, and organ transplantation.

Common Risk Factors

  • Common risk factors in the development of Lymphamatoid granulomatosis include:
    • EBV infection[1]
    • HIV infection[2]
    • Drug induced immunodeficiency[3]
    • Organ transplantation[4]


References

  1. Song JY, Pittaluga S, Dunleavy K, Grant N, White T, Jiang L, Davies-Hill T, Raffeld M, Wilson WH, Jaffe ES (February 2015). "Lymphomatoid granulomatosis--a single institute experience: pathologic findings and clinical correlations". Am. J. Surg. Pathol. 39 (2): 141–56. doi:10.1097/PAS.0000000000000328. PMC 4293220. PMID 25321327.
  2. Costiniuk, Cecilia T.; Karamchandani, Jason; Bessissow, Ali; Routy, Jean-Pierre; Szabo, Jason; Frenette, Charles (2018). "Angiocentric lymph proliferative disorder (lymphomatoid granulomatosis) in a person with newly-diagnosed HIV infection: a case report". BMC Infectious Diseases. 18 (1). doi:10.1186/s12879-018-3128-3. ISSN 1471-2334.
  3. Barakat, Athar; Grover, Karan; Peshin, Rohit (2014). "Rituximab for pulmonary lymphomatoid granulomatosis which developed as a complication of methotrexate and azathioprine therapy for rheumatoid arthritis". SpringerPlus. 3 (1): 751. doi:10.1186/2193-1801-3-751. ISSN 2193-1801.
  4. Shah, Sujal; Smith, Megan; Butler, Randall (2018). "A Case of Hodgkin Lymphoma Mimicking Lymphomatoid Granulomatosis Diagnosed at Autopsy". Laboratory Medicine. 49 (1): 80–86. doi:10.1093/labmed/lmx065. ISSN 0007-5027.

Template:WH Template:WS